Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Anthony R. Mato, MD

Anthony R. Mato, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Mato is a Penn Medicine employed physician.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2008
  • Medical Oncology, 2008

Clinical Expertise:

  • Chronic Lymphocytic Leukemia (CLL)
  • Lymphoma

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: State University of New York at Buffalo
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania


American College of Physician Executives, National American Society of Clinical Oncology, National American Society of Hematology, National Celgene Corporation: A Phase 3B randomized study of lenalidomide(CC-5013) plus rituximab maintenance therapy followed by lenalidomide single-agent maintenance versus rituximab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma , National National Cancer Institute , National

Hospital Affiliation

Dr. Mato is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Catherine Daniel, Anthony R. Mato: BCL-2 As a Therapeutic Target in Chronic Lymphocytic Leukemia Hematology & Oncology 15 (3): 2017 .

Mato AR, Timlin C, Ujjani C, Skarbnik A, Howlett C, Banerjee R, Nabhan C, Schuster SJ.: Comparable outcomes in Chronic Lymphocytic Leukemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-center study British Journal of Hematology : 2017 .

Schachter LG, Mato AR.: An update on immunotherapies including chimeric antigen receptor T-cells therapy and stem cell transplantation in chronic lymphocytic leukemia Translational Cancer Research : 2017 .

Mato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Karbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C.: Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi- Center Study of 683 Patients Annals of Oncology 25 : 2017 .

Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick DE, Kiselev P, Sharman, JP.: Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: Prospective evaluation on 455 patients treated in the United States BMC Cancer : 2017 .

Daniel Landsburg, Marissa Falkiewicz, Joseph Maly, Kristie A Blum, Christina Howlett, Tatyana Feldman, Anthony R Mato, Brian Hill, Shaoying Li, L. Jeffrey Medeiros, Pallawi Torka, Francisco Hernandez-Ilizaliturri, Nishitha Reddy, Arun Singavi, Timothy S Fenske, Julio Chavez, Jason Kaplan, Amir Behdad, Adam Petrich, Martin Alan Bast, Julie M Vose, Adam Olszewski, Cristiana Costa, Frederick Lansigan, James Gerson, Stefan K Barta, Oscar Calzada, Jonathon B Cohen, Jennifer Lue, Jennifer Amengual, Xavier Rivera,: Outcomes of double hit lymphoma patients who achieve first complete remission Journal of Clinical Oncology : 2017 .

Chadi Nabhan, Anthony R. Mato : Economic Modeling of the Cost of Chronic Lymphocytic Leukemia Therapy: It Is About the Model Journal of Clinical Oncology : 2017 .

Nabhan C, Mato AR, Feinberg BA.: Clinical Pathways in Chronic lymphocytic Leukemia: Challenges and Solutions American Journal of Hematology 92 (1): 5-6,2017.

Ayers EC, Mato A: Richter's Transformation in the Era of Kinase Inhibitor Therapy: A Review Clinical Lymphoma, Myeloma & Leukemia 17 (1): 1-6,2017.

Ryan CE, Sahaf B, Logan AC, O'Brien S, Byrd JC, Hillmen P, Brown JR, Dyer MJ, Mato AR, Keating MJ, Jaglowski S, Clow F, Rezvani AR, Styles L, Coutre SE, Miklos DB.: Ibrutinib Efficacy and Tolerability in Patients with Relapsed Chronic Lymphocytic Leukemia Following Allogeneic HCT BLOOD 128 (25): 2899-2908,2016 .

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-160
3400 Civic Center Blvd

Philadelphia, PA 19146
Phone: 215-615-7361
Fax: 215-615-5888
Patient appointments: 800-789-7366 (PENN)

Related Links